About Mike Mirizzi
Mike Mirizzi is a chief technology officer at Vantis Vascular.
Mike Mirizzi first appears on SEC filings in 2024.
Experience
This experience comes from Mike Mirizzi's profile and from SEC filings. For roles taken from filings, the years are when the filings name Mike Mirizzi in the role, so the role may have started earlier or lasted longer.
Vantis Vascular, Inc. Current
Chief Technology Officer
2022 – Present · San Jose, CA
Develops medical devices for cardiologists treating complex blood vessel conditions.
QI
QOOL THERAPEUTICS, INC.
Vice President, R&D
2014 – 2016
CI
Contact Vascular, Inc.
Co-Founder and COO
2014 – 2016
CO
COVIDIEN
Director of R&D, Technology and Product Development
2009 – 2013
VC
VNUS MEDICAL TECHNOLOGIES, INC. (Acquired by Covidien)
Director of R&D, New Product Incubation and Research (2005 – 2009)
Program Manager, Research and Development (2000 – 2005)
2000 – 2009
GD
GUIDANT CORPORATION, Compass Business Development Division
Project Group Leader, Neurovascular Venture Internal Startup
1999 – 2000
GI
GUIDANT CORPORATION, Vascular Intervention
Sr. R&D Lead Design Engineer
1996 – 1999
TI
TARGET THERAPEUTICS, INC.
Manufacturing Project Engineer
1996
Key Colleagues at Startups
The people Mike Mirizzi works with at each company, as listed on that company's latest Form D.
Vantis Vascular, Inc. · Form D, Jul 10, 2026
LP
Len Pinchuk
Director
Frank Saltiel
Chief Clinical Officer and director
Gary McCord
Chief Commercial Officer
Marc Monahan
Chief Financial Officer
Tim Fischell
Chief Medical Officer and director
Jason Turner
Chief Executive Officer and director